The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Research Report 2025
Synopsis
PET (Positron Emission Tomography) radioisotopes, also known as radiopharmaceuticals, are compounds containing radioactive isotopes that emit positrons. These radioisotopes are used in PET imaging to visualize and quantify biological processes within the body.
The global PET Radioisotope (Radiopharmaceuticals in PET Imaging) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for PET Radioisotope (Radiopharmaceuticals in PET Imaging) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for PET Radioisotope (Radiopharmaceuticals in PET Imaging) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of PET Radioisotope (Radiopharmaceuticals in PET Imaging) include IBA Molecular, GE Healthcare, Siemens Healthineers, Eli Lilly and Company, Mallinckrodt Pharmaceuticals, Blue Earth Diagnostics, ANSTO and ROSATOM, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for PET Radioisotope (Radiopharmaceuticals in PET Imaging), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PET Radioisotope (Radiopharmaceuticals in PET Imaging).
Report Scope
The PET Radioisotope (Radiopharmaceuticals in PET Imaging) market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global PET Radioisotope (Radiopharmaceuticals in PET Imaging) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the PET Radioisotope (Radiopharmaceuticals in PET Imaging) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
IBA Molecular
GE Healthcare
Siemens Healthineers
Eli Lilly and Company
Mallinckrodt Pharmaceuticals
Blue Earth Diagnostics
ANSTO
ROSATOM
Segment by Type
11C
13N
150
18F
Others
Segment by Application
Medical Imaging
Scientific Research
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of PET Radioisotope (Radiopharmaceuticals in PET Imaging) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of PET Radioisotope (Radiopharmaceuticals in PET Imaging) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of PET Radioisotope (Radiopharmaceuticals in PET Imaging) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
PET (Positron Emission Tomography) radioisotopes, also known as radiopharmaceuticals, are compounds containing radioactive isotopes that emit positrons. These radioisotopes are used in PET imaging to visualize and quantify biological processes within the body.
The global PET Radioisotope (Radiopharmaceuticals in PET Imaging) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for PET Radioisotope (Radiopharmaceuticals in PET Imaging) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for PET Radioisotope (Radiopharmaceuticals in PET Imaging) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of PET Radioisotope (Radiopharmaceuticals in PET Imaging) include IBA Molecular, GE Healthcare, Siemens Healthineers, Eli Lilly and Company, Mallinckrodt Pharmaceuticals, Blue Earth Diagnostics, ANSTO and ROSATOM, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for PET Radioisotope (Radiopharmaceuticals in PET Imaging), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PET Radioisotope (Radiopharmaceuticals in PET Imaging).
Report Scope
The PET Radioisotope (Radiopharmaceuticals in PET Imaging) market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global PET Radioisotope (Radiopharmaceuticals in PET Imaging) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the PET Radioisotope (Radiopharmaceuticals in PET Imaging) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
IBA Molecular
GE Healthcare
Siemens Healthineers
Eli Lilly and Company
Mallinckrodt Pharmaceuticals
Blue Earth Diagnostics
ANSTO
ROSATOM
Segment by Type
11C
13N
150
18F
Others
Segment by Application
Medical Imaging
Scientific Research
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of PET Radioisotope (Radiopharmaceuticals in PET Imaging) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of PET Radioisotope (Radiopharmaceuticals in PET Imaging) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of PET Radioisotope (Radiopharmaceuticals in PET Imaging) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Overview
1.1 Product Definition
1.2 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Segment by Type
1.2.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 11C
1.2.3 13N
1.2.4 150
1.2.5 18F
1.2.6 Others
1.3 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Segment by Application
1.3.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Medical Imaging
1.3.3 Scientific Research
1.4 Global Market Growth Prospects
1.4.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Estimates and Forecasts (2019-2030)
1.4.4 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Market Share by Manufacturers (2019-2024)
2.2 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of PET Radioisotope (Radiopharmaceuticals in PET Imaging), Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of PET Radioisotope (Radiopharmaceuticals in PET Imaging), Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of PET Radioisotope (Radiopharmaceuticals in PET Imaging), Product Offered and Application
2.8 Global Key Manufacturers of PET Radioisotope (Radiopharmaceuticals in PET Imaging), Date of Enter into This Industry
2.9 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Competitive Situation and Trends
2.9.1 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Concentration Rate
2.9.2 Global 5 and 10 Largest PET Radioisotope (Radiopharmaceuticals in PET Imaging) Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production by Region
3.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value by Region (2019-2030)
3.2.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of PET Radioisotope (Radiopharmaceuticals in PET Imaging) by Region (2025-2030)
3.3 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production by Region (2019-2030)
3.4.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of PET Radioisotope (Radiopharmaceuticals in PET Imaging) by Region (2025-2030)
3.5 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Price Analysis by Region (2019-2024)
3.6 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production and Value, Year-over-Year Growth
3.6.1 North America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Estimates and Forecasts (2019-2030)
3.6.3 China PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Estimates and Forecasts (2019-2030)
4 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption by Region
4.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption by Region (2019-2030)
4.2.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption by Region (2019-2024)
4.2.2 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption by Country (2019-2030)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Netherlands
4.5 Asia Pacific
4.5.1 Asia Pacific PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production by Type (2019-2030)
5.1.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production by Type (2019-2024)
5.1.2 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production by Type (2025-2030)
5.1.3 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Market Share by Type (2019-2030)
5.2 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value by Type (2019-2030)
5.2.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value by Type (2019-2024)
5.2.2 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value by Type (2025-2030)
5.2.3 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Market Share by Type (2019-2030)
5.3 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Price by Type (2019-2030)
6 Segment by Application
6.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production by Application (2019-2030)
6.1.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production by Application (2019-2024)
6.1.2 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production by Application (2025-2030)
6.1.3 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Market Share by Application (2019-2030)
6.2 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value by Application (2019-2030)
6.2.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value by Application (2019-2024)
6.2.2 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value by Application (2025-2030)
6.2.3 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Market Share by Application (2019-2030)
6.3 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Price by Application (2019-2030)
7 Key Companies Profiled
7.1 IBA Molecular
7.1.1 IBA Molecular PET Radioisotope (Radiopharmaceuticals in PET Imaging) Corporation Information
7.1.2 IBA Molecular PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product Portfolio
7.1.3 IBA Molecular PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production, Value, Price and Gross Margin (2019-2024)
7.1.4 IBA Molecular Main Business and Markets Served
7.1.5 IBA Molecular Recent Developments/Updates
7.2 GE Healthcare
7.2.1 GE Healthcare PET Radioisotope (Radiopharmaceuticals in PET Imaging) Corporation Information
7.2.2 GE Healthcare PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product Portfolio
7.2.3 GE Healthcare PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production, Value, Price and Gross Margin (2019-2024)
7.2.4 GE Healthcare Main Business and Markets Served
7.2.5 GE Healthcare Recent Developments/Updates
7.3 Siemens Healthineers
7.3.1 Siemens Healthineers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Corporation Information
7.3.2 Siemens Healthineers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product Portfolio
7.3.3 Siemens Healthineers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Siemens Healthineers Main Business and Markets Served
7.3.5 Siemens Healthineers Recent Developments/Updates
7.4 Eli Lilly and Company
7.4.1 Eli Lilly and Company PET Radioisotope (Radiopharmaceuticals in PET Imaging) Corporation Information
7.4.2 Eli Lilly and Company PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product Portfolio
7.4.3 Eli Lilly and Company PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Eli Lilly and Company Main Business and Markets Served
7.4.5 Eli Lilly and Company Recent Developments/Updates
7.5 Mallinckrodt Pharmaceuticals
7.5.1 Mallinckrodt Pharmaceuticals PET Radioisotope (Radiopharmaceuticals in PET Imaging) Corporation Information
7.5.2 Mallinckrodt Pharmaceuticals PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product Portfolio
7.5.3 Mallinckrodt Pharmaceuticals PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Mallinckrodt Pharmaceuticals Main Business and Markets Served
7.5.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
7.6 Blue Earth Diagnostics
7.6.1 Blue Earth Diagnostics PET Radioisotope (Radiopharmaceuticals in PET Imaging) Corporation Information
7.6.2 Blue Earth Diagnostics PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product Portfolio
7.6.3 Blue Earth Diagnostics PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Blue Earth Diagnostics Main Business and Markets Served
7.6.5 Blue Earth Diagnostics Recent Developments/Updates
7.7 ANSTO
7.7.1 ANSTO PET Radioisotope (Radiopharmaceuticals in PET Imaging) Corporation Information
7.7.2 ANSTO PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product Portfolio
7.7.3 ANSTO PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production, Value, Price and Gross Margin (2019-2024)
7.7.4 ANSTO Main Business and Markets Served
7.7.5 ANSTO Recent Developments/Updates
7.8 ROSATOM
7.8.1 ROSATOM PET Radioisotope (Radiopharmaceuticals in PET Imaging) Corporation Information
7.8.2 ROSATOM PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product Portfolio
7.8.3 ROSATOM PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production, Value, Price and Gross Margin (2019-2024)
7.8.4 ROSATOM Main Business and Markets Served
7.7.5 ROSATOM Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Industry Chain Analysis
8.2 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Mode & Process
8.4 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales and Marketing
8.4.1 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Channels
8.4.2 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Distributors
8.5 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Customers
9 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Dynamics
9.1 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Industry Trends
9.2 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Drivers
9.3 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Challenges
9.4 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of TablesList of Tables
Table 1. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Value by Type, (US$ Million) & (2023 VS 2030)
Table 2. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Value by Application, (US$ Million) & (2023 VS 2030)
Table 3. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Capacity (Tons) by Manufacturers in 2023
Table 4. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production by Manufacturers (2019-2024) & (Tons)
Table 5. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Market Share by Manufacturers (2019-2024)
Table 6. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value by Manufacturers (2019-2024) & (US$ Million)
Table 7. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Share by Manufacturers (2019-2024)
Table 8. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Industry Ranking 2022 VS 2023 VS 2024
Table 9. Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in PET Radioisotope (Radiopharmaceuticals in PET Imaging) as of 2023)
Table 10. Global Market PET Radioisotope (Radiopharmaceuticals in PET Imaging) Average Price by Manufacturers (US$/Ton) & (2019-2024)
Table 11. Manufacturers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Sites and Area Served
Table 12. Manufacturers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product Types
Table 13. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion
Table 15. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 16. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value (US$ Million) by Region (2019-2024)
Table 17. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Market Share by Region (2019-2024)
Table 18. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value (US$ Million) Forecast by Region (2025-2030)
Table 19. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Market Share Forecast by Region (2025-2030)
Table 20. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Comparison by Region: 2019 VS 2023 VS 2030 (Tons)
Table 21. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (Tons) by Region (2019-2024)
Table 22. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Market Share by Region (2019-2024)
Table 23. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (Tons) Forecast by Region (2025-2030)
Table 24. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Market Share Forecast by Region (2025-2030)
Table 25. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Average Price (US$/Ton) by Region (2019-2024)
Table 26. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Average Price (US$/Ton) by Region (2025-2030)
Table 27. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (Tons)
Table 28. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption by Region (2019-2024) & (Tons)
Table 29. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Market Share by Region (2019-2024)
Table 30. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Forecasted Consumption by Region (2025-2030) & (Tons)
Table 31. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Forecasted Consumption Market Share by Region (2019-2024)
Table 32. North America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Tons)
Table 33. North America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption by Country (2019-2024) & (Tons)
Table 34. North America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption by Country (2025-2030) & (Tons)
Table 35. Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Tons)
Table 36. Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption by Country (2019-2024) & (Tons)
Table 37. Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption by Country (2025-2030) & (Tons)
Table 38. Asia Pacific PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (Tons)
Table 39. Asia Pacific PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption by Region (2019-2024) & (Tons)
Table 40. Asia Pacific PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption by Region (2025-2030) & (Tons)
Table 41. Latin America, Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Tons)
Table 42. Latin America, Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption by Country (2019-2024) & (Tons)
Table 43. Latin America, Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption by Country (2025-2030) & (Tons)
Table 44. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (Tons) by Type (2019-2024)
Table 45. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (Tons) by Type (2025-2030)
Table 46. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Market Share by Type (2019-2024)
Table 47. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Market Share by Type (2025-2030)
Table 48. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value (US$ Million) by Type (2019-2024)
Table 49. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value (US$ Million) by Type (2025-2030)
Table 50. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Share by Type (2019-2024)
Table 51. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Share by Type (2025-2030)
Table 52. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Price (US$/Ton) by Type (2019-2024)
Table 53. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Price (US$/Ton) by Type (2025-2030)
Table 54. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (Tons) by Application (2019-2024)
Table 55. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (Tons) by Application (2025-2030)
Table 56. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Market Share by Application (2019-2024)
Table 57. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Market Share by Application (2025-2030)
Table 58. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value (US$ Million) by Application (2019-2024)
Table 59. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value (US$ Million) by Application (2025-2030)
Table 60. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Share by Application (2019-2024)
Table 61. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Share by Application (2025-2030)
Table 62. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Price (US$/Ton) by Application (2019-2024)
Table 63. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Price (US$/Ton) by Application (2025-2030)
Table 64. IBA Molecular PET Radioisotope (Radiopharmaceuticals in PET Imaging) Corporation Information
Table 65. IBA Molecular Specification and Application
Table 66. IBA Molecular PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 67. IBA Molecular Main Business and Markets Served
Table 68. IBA Molecular Recent Developments/Updates
Table 69. GE Healthcare PET Radioisotope (Radiopharmaceuticals in PET Imaging) Corporation Information
Table 70. GE Healthcare Specification and Application
Table 71. GE Healthcare PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 72. GE Healthcare Main Business and Markets Served
Table 73. GE Healthcare Recent Developments/Updates
Table 74. Siemens Healthineers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Corporation Information
Table 75. Siemens Healthineers Specification and Application
Table 76. Siemens Healthineers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 77. Siemens Healthineers Main Business and Markets Served
Table 78. Siemens Healthineers Recent Developments/Updates
Table 79. Eli Lilly and Company PET Radioisotope (Radiopharmaceuticals in PET Imaging) Corporation Information
Table 80. Eli Lilly and Company Specification and Application
Table 81. Eli Lilly and Company PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 82. Eli Lilly and Company Main Business and Markets Served
Table 83. Eli Lilly and Company Recent Developments/Updates
Table 84. Mallinckrodt Pharmaceuticals PET Radioisotope (Radiopharmaceuticals in PET Imaging) Corporation Information
Table 85. Mallinckrodt Pharmaceuticals Specification and Application
Table 86. Mallinckrodt Pharmaceuticals PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 87. Mallinckrodt Pharmaceuticals Main Business and Markets Served
Table 88. Mallinckrodt Pharmaceuticals Recent Developments/Updates
Table 89. Blue Earth Diagnostics PET Radioisotope (Radiopharmaceuticals in PET Imaging) Corporation Information
Table 90. Blue Earth Diagnostics Specification and Application
Table 91. Blue Earth Diagnostics PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 92. Blue Earth Diagnostics Main Business and Markets Served
Table 93. Blue Earth Diagnostics Recent Developments/Updates
Table 94. ANSTO PET Radioisotope (Radiopharmaceuticals in PET Imaging) Corporation Information
Table 95. ANSTO Specification and Application
Table 96. ANSTO PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 97. ANSTO Main Business and Markets Served
Table 98. ANSTO Recent Developments/Updates
Table 99. ROSATOM PET Radioisotope (Radiopharmaceuticals in PET Imaging) Corporation Information
Table 100. ROSATOM Specification and Application
Table 101. ROSATOM PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 102. ROSATOM Main Business and Markets Served
Table 103. ROSATOM Recent Developments/Updates
Table 104. Key Raw Materials Lists
Table 105. Raw Materials Key Suppliers Lists
Table 106. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Distributors List
Table 107. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Customers List
Table 108. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Trends
Table 109. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Drivers
Table 110. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Challenges
Table 111. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Restraints
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of PET Radioisotope (Radiopharmaceuticals in PET Imaging)
Figure 2. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Value by Type, (US$ Million) & (2023 VS 2030)
Figure 3. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Share by Type: 2023 VS 2030
Figure 4. 11C Product Picture
Figure 5. 13N Product Picture
Figure 6. 150 Product Picture
Figure 7. 18F Product Picture
Figure 8. Others Product Picture
Figure 9. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Value by Application, (US$ Million) & (2023 VS 2030)
Figure 10. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Share by Application: 2023 VS 2030
Figure 11. Medical Imaging
Figure 12. Scientific Research
Figure 13. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value (US$ Million) & (2019-2030)
Figure 15. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Capacity (Tons) & (2019-2030)
Figure 16. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (Tons) & (2019-2030)
Figure 17. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Average Price (US$/Ton) & (2019-2030)
Figure 18. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Report Years Considered
Figure 19. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Share by Manufacturers in 2023
Figure 20. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 21. The Global 5 and 10 Largest Players: Market Share by PET Radioisotope (Radiopharmaceuticals in PET Imaging) Revenue in 2023
Figure 22. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 23. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Market Share by Region: 2019 VS 2023 VS 2030
Figure 24. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Comparison by Region: 2019 VS 2023 VS 2030 (Tons)
Figure 25. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Market Share by Region: 2019 VS 2023 VS 2030
Figure 26. North America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value (US$ Million) Growth Rate (2019-2030)
Figure 27. Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value (US$ Million) Growth Rate (2019-2030)
Figure 28. China PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value (US$ Million) Growth Rate (2019-2030)
Figure 29. Japan PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value (US$ Million) Growth Rate (2019-2030)
Figure 30. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption by Region: 2019 VS 2023 VS 2030 (Tons)
Figure 31. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Market Share by Region: 2019 VS 2023 VS 2030
Figure 32. North America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption and Growth Rate (2019-2024) & (Tons)
Figure 33. North America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Market Share by Country (2019-2030)
Figure 34. Canada PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption and Growth Rate (2019-2024) & (Tons)
Figure 35. U.S. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption and Growth Rate (2019-2024) & (Tons)
Figure 36. Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption and Growth Rate (2019-2024) & (Tons)
Figure 37. Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Market Share by Country (2019-2030)
Figure 38. Germany PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption and Growth Rate (2019-2024) & (Tons)
Figure 39. France PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption and Growth Rate (2019-2024) & (Tons)
Figure 40. U.K. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption and Growth Rate (2019-2024) & (Tons)
Figure 41. Italy PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption and Growth Rate (2019-2024) & (Tons)
Figure 42. Russia PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption and Growth Rate (2019-2024) & (Tons)
Figure 43. Asia Pacific PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption and Growth Rate (2019-2024) & (Tons)
Figure 44. Asia Pacific PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Market Share by Regions (2019-2030)
Figure 45. China PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption and Growth Rate (2019-2024) & (Tons)
Figure 46. Japan PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption and Growth Rate (2019-2024) & (Tons)
Figure 47. South Korea PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption and Growth Rate (2019-2024) & (Tons)
Figure 48. China Taiwan PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption and Growth Rate (2019-2024) & (Tons)
Figure 49. Southeast Asia PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption and Growth Rate (2019-2024) & (Tons)
Figure 50. India PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption and Growth Rate (2019-2024) & (Tons)
Figure 51. Latin America, Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption and Growth Rate (2019-2024) & (Tons)
Figure 52. Latin America, Middle East & Africa PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Market Share by Country (2019-2030)
Figure 53. Mexico PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption and Growth Rate (2019-2024) & (Tons)
Figure 54. Brazil PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption and Growth Rate (2019-2024) & (Tons)
Figure 55. Turkey PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption and Growth Rate (2019-2024) & (Tons)
Figure 56. GCC Countries PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption and Growth Rate (2019-2024) & (Tons)
Figure 57. Global Production Market Share of PET Radioisotope (Radiopharmaceuticals in PET Imaging) by Type (2019-2030)
Figure 58. Global Production Value Market Share of PET Radioisotope (Radiopharmaceuticals in PET Imaging) by Type (2019-2030)
Figure 59. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Price (US$/Ton) by Type (2019-2030)
Figure 60. Global Production Market Share of PET Radioisotope (Radiopharmaceuticals in PET Imaging) by Application (2019-2030)
Figure 61. Global Production Value Market Share of PET Radioisotope (Radiopharmaceuticals in PET Imaging) by Application (2019-2030)
Figure 62. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Price (US$/Ton) by Application (2019-2030)
Figure 63. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Value Chain
Figure 64. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Process
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Distributors Profiles
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
